![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 24, 21062-21069, June 15, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
From the Differential splicing from the bcl-X
gene generates several isoforms with opposite effects on the apoptotic
response. To explore the mechanism controlling the balance between the
various isoforms, we have characterized the 5' region of the mouse
bcl-X gene. We identified three new promoters in addition
to the two previously described (Grillot, D. A., M., G.-G.,
Ekhterae, D., Duan, L., Inohara, N., Ohta, S., Seldin, M. F., and
Núñez, G. (1997) J. Immunol. 158, 4750-4757). These five promoters (P1-P5) would give rise to at least
five mRNAs with different 5'-untranslated region, all sharing the
same translation initiation site. Except for the product of the most
proximal promoter (P1), the other mRNAs are generated by
alternative splicing of noncoding exons to a common acceptor site
located in the first translated exon. Reverse transcriptase-polymerase chain reaction, primer extension, and RNase protection assays demonstrate a tissue-specific pattern of promoter usage. P1 and P2 are
active in all tissues analyzed, whereas the other three promoter show
tissue-specific activities. P3 is active in spleen, liver, and kidney,
P4 is active in uterus and spleen, and P5 is active in spleen, liver,
brain, and thymus. We present evidence suggesting that promoter
selection influences the outcome of the splice process. Transcripts
from P1 generate mainly the mRNA for the long isoform
Bcl-XL, whereas transcripts from P2 generate mRNAs for
the isoforms Bcl-XL, Bcl-XS, and
Bcl-X
Institut für Molekularbiologie und
Tumorforschung (IMT), Marburg 35033, Germany and
§ Departamento de Química Biológica, Facultad
de Ciencias Exactas y Naturales, Universidad de Buenos Aires,
and Instituto de Biología y Medicina Experimental (IByME),
Consejo Nacional de Investigaciones Científicas y
Técnicas, Buenos Aires 1428, Argentina
and transcripts from P3 yield mainly mRNAs for
the isoform Bcl-X
. Our results suggest a key role of
promoter choice in determining alternative splicing and, thus, the
balance of Bcl-X isoforms.
To whom correspondence should be addressed. Tel.:
49-6421-28-6286; Fax: 49-6421-28-5398: E-mail:
beato@imt.uni-marburg.de.
This article has been cited by other articles:
![]() |
J. Zhang, G. Tsaprailis, and G. T. Bowden Nucleolin Stabilizes Bcl-XL Messenger RNA in Response to UVA Irradiation Cancer Res., February 15, 2008; 68(4): 1046 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Revil, J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing Mol. Cell. Biol., December 15, 2007; 27(24): 8431 - 8441. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Suzuki, H. Nagase, C. M. Wong, S. V. Kumar, V. Jain, A.-M. Park, and R. M. Day Regulation of Bcl-xL Expression in Lung Vascular Smooth Muscle Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 678 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Jenkins, A. Swiatoniowski, M. R. Power, and T.-J. Lin Pseudomonas aeruginosa-Induced Human Mast Cell Apoptosis Is Associated with Up-Regulation of Endogenous Bcl-xS and Down-Regulation of Bcl-xL J. Immunol., December 1, 2006; 177(11): 8000 - 8007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Vitiello, R. J. Staversky, S. C. Gehen, C. J. Johnston, J. N. Finkelstein, T. W. Wright, and M. A. O'Reilly p21Cip1 Protection against Hyperoxia Requires Bcl-XL and Is Uncoupled from Its Ability to Suppress Growth Am. J. Pathol., June 1, 2006; 168(6): 1838 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tao, D. Yan, Q. Yang, R. Zeng, and Y. Wang Low K+ Promotes NF-{kappa}B/DNA Binding in Neuronal Apoptosis Induced by K+ Loss Mol. Cell. Biol., February 1, 2006; 26(3): 1038 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. Ringquist, A. H. Cho, G. Rondeau, and J. Welsh High-throughput polyribosome fractionation Nucleic Acids Res., June 1, 2004; 32(10): e79 - e79. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4 J. Biol. Chem., March 12, 2004; 279(11): 9831 - 9839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Valks, T. J. Kemp, and A. Clerk Regulation of Bcl-xL Expression by H2O2 in Cardiac Myocytes J. Biol. Chem., July 3, 2003; 278(28): 25542 - 25547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. POLLOCK, J. TURCK, and D. H. LOVETT The prodomain of interleukin 1{alpha} interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells FASEB J, February 1, 2003; 17(2): 203 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zaldumbide, F. Carlotti, P. Pognonec, and K. E. Boulukos The Role of the Ets2 Transcription Factor in the Proliferation, Maturation, and Survival of Mouse Thymocytes J. Immunol., November 1, 2002; 169(9): 4873 - 4881. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |